XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total
Balance at Dec. 31, 2018 $ 7 $ 232,243 $ (197,304) $ (4)  
Balance (in shares) at Dec. 31, 2018 7,141,996        
Increase (Decrease) in Shareholders' Equity          
Issuance of common stock in at-the-market offerings $ 1 3,223      
Issuance of common stock in at-the-market offerings (in shares) 564,590        
Issuance of common stock and warrants in public offerings $ 4 18,501      
Issuance of common stock and warrants in public offerings (in shares) 4,000,000        
Issuance of common stock upon exercise of common stock warrants   54      
Issuance of common stock upon exercise of common stock warrants (in shares) 8,700        
Stock-based compensation expense   1,227      
Realized (loss) gain on short-term investments       4 $ 4
Net loss     (19,683)   (19,683)
Balance at Sep. 30, 2019 $ 12 255,248 (216,987)   38,273
Balance (in shares) at Sep. 30, 2019 11,715,286        
Balance at Jun. 30, 2019 $ 12 253,821 (210,473) 1  
Balance (in shares) at Jun. 30, 2019 11,553,937        
Increase (Decrease) in Shareholders' Equity          
Issuance of common stock in at-the-market offerings   1,049      
Issuance of common stock in at-the-market offerings (in shares) 161,349        
Stock-based compensation expense   378      
Realized (loss) gain on short-term investments       (1) (1)
Net loss     (6,514)   (6,514)
Balance at Sep. 30, 2019 $ 12 255,248 (216,987)   38,273
Balance (in shares) at Sep. 30, 2019 11,715,286        
Balance at Dec. 31, 2019 $ 12 259,305 (223,597)   $ 35,720
Balance (in shares) at Dec. 31, 2019 12,433,600       12,433,600
Increase (Decrease) in Shareholders' Equity          
Issuance of common stock in at-the-market offerings $ 3 16,267      
Issuance of common stock in at-the-market offerings (in shares) 2,353,737        
Issuance of common stock and warrants in public offerings $ 5 24,554      
Issuance of common stock and warrants in public offerings (in shares) 5,290,000        
Stock-based compensation expense   1,084      
Net loss     (28,322)   $ (28,322)
Balance at Sep. 30, 2020 $ 20 301,210 (251,919)   $ 49,311
Balance (in shares) at Sep. 30, 2020 20,077,337       20,077,337
Balance at Jun. 30, 2020 $ 19 291,897 (241,057) 1  
Balance (in shares) at Jun. 30, 2020 18,823,601        
Increase (Decrease) in Shareholders' Equity          
Issuance of common stock in at-the-market offerings $ 1 8,938      
Issuance of common stock in at-the-market offerings (in shares) 1,253,736        
Stock-based compensation expense   375      
Realized (loss) gain on short-term investments       $ (1) $ (1)
Net loss     (10,862)   (10,862)
Balance at Sep. 30, 2020 $ 20 $ 301,210 $ (251,919)   $ 49,311
Balance (in shares) at Sep. 30, 2020 20,077,337       20,077,337